Exploring Concurrent Validity and Item Level Analysis for Two Korean Versions of Health-Related Quality of Life Instrument: EQ-5D vs. WHOQOL-BREF

  • Choi, Bongsam (Department of Physical Therapy, College of Health and Welfare, Woosong University)
  • Received : 2020.10.21
  • Accepted : 2020.10.26
  • Published : 2020.11.20


Background: Cross-culturally adapted questionnaires may not be comparable to their original version. Objects: To examine concurrent validity of two health-related quality of life (HRQOL) instruments for the Korean versions of EuroQOL-5 Dimension (EQ-5D) and the abbreviated version of the World Health Organization Quality of Life (WHOQOL-BREF) instrument. Methods: A total of 139 cancer survivors from two rehabilitation institutes was recruited. All participants were registered for palliative rehabilitation care. Both instruments were concurrently administered by health care providers following the second bout of the rehabilitation cares. Rasch partial credit model and Spearman's correlation analysis were used to investigate: 1) dimensionality, 2) hierarchical item difficulty, and 3) concurrent validity using correlations between two instruments. Results: For the WHOQOL-BREF, all items except negative feeling, pain, dependence of medical aid, were found to be acceptable, while all items of EQ-5D were acceptable. There was an evidence of negative correlations between EQ-5D and 4 domains of WHOQOL-BREF. Two correlations were strong (EQ-5D vs. physical health domain, ρ = -0.610, 95% CI = -0.716 to -0.475) and moderate (EQ-5D vs. psychosocial domain, ρ = -0.402, 95% CI = -0.546 to -0.236). Other two correlations were weak (EQ-5D vs. social relationship and environmental domains, ρ = -0.242, 95% CI = -0.401 to -0.075 and ρ = -0.364, 95% CI = -0.514 to -0.207, respectively). Item difficulty calibrations of the two measurements were ranged from -0.84 to 0.86 for the EQ-5D and -1.07 to 1.06 for the WHOQOL-BREF. Conclusion: The study provides some supports for the concurrent validity of the two Korean versions of HRQOL instrument, with evidences of weak to strong correlations between the EQ-5D and four domains of the WHOQOL-BREF applied to various cancer survivors. Additionally, the cancer survivors appeared to have more of a tendency to view the EQ-5D items as being slightly more challenging than the WHOQOL-BREF items.


  1. Ringdal GI, Jordhoy MS, Kaasa S. Measuring quality of palliative care: psychometric properties of the FAMCARE Scale. Qual Life Res 2003;12(2):167-76.
  2. Kaasa S, Loge JH. Quality of life in palliative care: principles and practice. Palliat Med 2003;17(1):11-20.
  3. Pirl WF, Greer JA, Traeger L, Jackson V, Lennes IT, Gallagher ER, et al. Depression and survival in metastatic non-smallcell lung cancer: effects of early palliative care. J Clin Oncol 2012;30(12):1310-5.
  4. Greer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Heist RS, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 2012;30(4):394-400.
  5. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363(8):733-42.
  6. United Nations. World population prospects: the 2017 revision. Key findings & advance tables. New York: United Nations;2017.
  7. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46(12):1417-32.
  8. Schmidt S, Bullinger M. Current issues in cross-cultural quality of life instrument development. Arch Phys Med Rehabil 2003;84(4 Suppl 2):S29-34.
  9. Caplan N, Robson H, Robson A, Kelly M, Wilkes G. Changes in health-related quality of life (EQ-5D) dimensions associated with community-based musculoskeletal physiotherapy: a multi-centre analysis. Qual Life Res 2018;27(9):2373-82.
  10. Suarez L, Tay B, Abdullah F. Psychometric properties of the World Health Organization WHOQOL-BREF Quality of Life assessment in Singapore. Qual Life Res 2018;27(11):2945-52.
  11. World Health Organization. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46(12):1569-85.
  12. Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004;13(2):299-310.
  13. Skevington SM, Sartorius N, Amir M. Developing methods for assessing quality of life in different cultural settings. The history of the WHOQOL instruments. Soc Psychiatry Psychiatr Epidemiol 2004;39(1):1-8.
  14. Lin CY, Hwang JS, Wang WC, Lai WW, Su WC, Wu TY, et al. Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis. J Formos Med Assoc 2019;118(1 Pt 2):215-22.
  15. Skevington SM. Advancing cross-cultural research on quality of life: observations drawn from the WHOQOL development. World Health Organisation Quality of Life Assessment. Qual Life Res 2002;11(2):135-44.
  16. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998;28(3):551-8.
  17. Dauden E, Griffiths CE, Ortonne JP, Kragballe K, Molta CT, Robertson D, et al. Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study. J Eur Acad Dermatol Venereol 2009;23(12):1374-82.
  18. Luger TA, Barker J, Lambert J, Yang S, Robertson D, Foehl J, et al. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol 2009;23(8):896-904.
  19. van de Kerkhof PC. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br J Dermatol 2004;151(3):663-8.
  20. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002;47(4):512-8.
  21. International Agency for Research on Cancer. World cancer report: cancer research for cancer prevention. International Agency for Research on Cancer [Internet]. Lyon [cited 2020 Aug 13]. Available from:
  22. Endarti D, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, Hutubessy R, Kristina SA. Evaluation of healthrelated quality of life among patients with cervical cancer in Indonesia. Asian Pac J Cancer Prev 2015;16(8):3345-50.
  23. Sewtz C, Muscheites W, Kriesen U, Grosse-Thie C, Kragl B, Panse J, et al. Questionnaires measuring quality of life and satisfaction of patients and their relatives in a palliative care setting-German translation of FAMCARE-2 and the palliative care subscale of FACIT-Pal. Ann Palliat Med 2018;7(4):420-6.
  24. Danielsen AK, Pommergaard HC, Burcharth J, Angenete E, Rosenberg J. Translation of questionnaires measuring health related quality of life is not standardized: a literature based research study. PLoS One 2015;10(5):e0127050.
  25. Danielsen AK, Rosenberg J. Health related quality of life may increase when patients with a stoma attend patient education--a case-control study. PLoS One 2014;9(3):e90354.
  26. Perera HN, Izadikhah Z, O'Connor P, McIlveen P. Resolving dimensionality problems with WHOQOL-BREF item responses. Assessment 2018;25(8):1014-25.
  27. McHorney CA. Health status assessment methods for adults: past accomplishments and future challenges. Annu Rev Public Health 1999;20:309-35.
  28. Oliveira IS, da Cunha Menezes Costa L, Fagundes FR, Cabral CM. Evaluation of cross-cultural adaptation and measurement properties of breast cancer-specific quality-of-life questionnaires: a systematic review. Qual Life Res 2015;24(5):1179-95.
  29. Liang MH, Lew RA, Stucki G, Fortin PR, Daltroy L. Measuring clinically important changes with patient-oriented questionnaires. Med Care 2002;40(4 Suppl):II45-51.
  30. McHorney CA. Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med 1997;127(8 Pt 2):743-50.
  31. Ashley L, Smith AB, Jones H, Velikova G, Wright P. Traditional and Rasch psychometric analyses of the Quality of Life in Adult Cancer Survivors (QLACS) questionnaire in shorter-term cancer survivors 15 months post-diagnosis. J Psychosom Res 2014;77(4):322-9.
  32. Gershon R, Cella D, Dineen K, Rosenbloom S, Peterman A, Lai JS. Item response theory and health-related quality of life in cancer. Expert Rev Pharmacoecon Outcomes Res 2003;3(6):783-91.
  33. Anota A, Bascoul-Mollevi C, Conroy T, Guillemin F, Velten M, Jolly D, et al. Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients. Health Qual Life Outcomes 2014;12:32.
  34. Boyer L, Baumstarck K, Michel P, Boucekine M, Anota A, Bonnetain F, et al. Statistical challenges of quality of life and cancer: new avenues for future research. Expert Rev Pharmacoecon Outcomes Res 2014;14(1):19-22.
  35. Rao D, Debb S, Blitz D, Choi SW, Cella D. Racial/Ethnic differences in the health-related quality of life of cancer patients. J Pain Symptom Manage 2008;36(5):488-96.
  36. Pagano IS, Gotay CC. Ethnic differential item functioning in the assessment of quality of life in cancer patients. Health Qual Life Outcomes 2005;3:60.
  37. Gamper EM, Groenvold M, Petersen MA, Young T, Costantini A, Aaronson N, et al. The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development. Psychooncology 2014;23(4):397-403.
  38. Min SK, Kim KI, Lee CI, Jung YC, Suh SY, Kim DK. Development of the Korean versions of WHO Quality of Life scale and WHOQOL-BREF. Qual Life Res 2002;11(6):593-600.
  39. Kim SH, Ahn J, Ock M, Shin S, Park J, Luo N, et al. The EQ-5D-5L valuation study in Korea. Qual Life Res 2016;25(7):1845-52.
  40. Bond TG, Fox CM. Applying the Rasch model: fundamental measurement in the human sciences. 3rd ed. Hoboken: Taylor and Francis; 2015;26-7.
  41. Evans JD. Straightforward statistics for the behavioral sciences. Pacific Grove: Brooks/Cole Publishing Company; 1996;43-56.
  42. Lee JY. Uses of clinical databases. Am J Med Sci 1994;308(1):58-62.